Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SCN11A | SNV | Missense_Mutation | rs760681852 | c.2008N>T | p.Arg670Cys | p.R670C | Q9UI33 | protein_coding | deleterious(0) | possibly_damaging(0.873) | TCGA-BH-A0E0-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD |
SCN11A | SNV | Missense_Mutation | | c.553N>G | p.Leu185Val | p.L185V | Q9UI33 | protein_coding | tolerated(0.32) | benign(0.11) | TCGA-BH-A0HP-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | doxorubicin | SD |
SCN11A | SNV | Missense_Mutation | | c.3470N>T | p.Ala1157Val | p.A1157V | Q9UI33 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-C8-A274-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD |
SCN11A | SNV | Missense_Mutation | | c.998N>C | p.Ile333Thr | p.I333T | Q9UI33 | protein_coding | tolerated(0.42) | benign(0.001) | TCGA-D8-A147-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicine | SD |
SCN11A | SNV | Missense_Mutation | rs372078622 | c.2288G>A | p.Arg763His | p.R763H | Q9UI33 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-D8-A1JD-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
SCN11A | SNV | Missense_Mutation | rs778354128 | c.2239N>T | p.Arg747Trp | p.R747W | Q9UI33 | protein_coding | deleterious(0.01) | probably_damaging(0.987) | TCGA-D8-A1XQ-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SCN11A | SNV | Missense_Mutation | | c.131N>A | p.Thr44Lys | p.T44K | Q9UI33 | protein_coding | tolerated(0.99) | benign(0.001) | TCGA-D8-A1XQ-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SCN11A | SNV | Missense_Mutation | | c.4093N>G | p.Ser1365Gly | p.S1365G | Q9UI33 | protein_coding | deleterious(0.03) | benign(0.026) | TCGA-D8-A1Y3-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicine+cyclophosphamide | SD |
SCN11A | SNV | Missense_Mutation | rs191164627 | c.4528N>G | p.Ile1510Val | p.I1510V | Q9UI33 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-E2-A1LE-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | herceptin | PD |
SCN11A | SNV | Missense_Mutation | | c.977A>T | p.Tyr326Phe | p.Y326F | Q9UI33 | protein_coding | tolerated(0.43) | benign(0.003) | TCGA-E2-A1LH-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL3545209 | NKTR-171 | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL918 | PHENACEMIDE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL1200341 | INDECAINIDE HYDROCHLORIDE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL1201754 | RUFINAMIDE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | | Tolperisone | TOLPERISONE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL1201022 | PHENAZOPYRIDINE HYDROCHLORIDE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL1194 | PRILOCAINE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL919 | FOSPHENYTOIN SODIUM | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | blocker | CHEMBL1200440 | MEPIVACAINE HYDROCHLORIDE | |
11280 | SCN11A | DRUGGABLE GENOME, ION CHANNEL, KINASE | | Lidocaine | LIDOCAINE | |